Recommended surveillance guidelines for patients at high risk for HCC include abdominal imaging, using ultrasonography coupled with serum alpha-fetoprotein (AFP) measurement, followed by dynamic computed tomography (CT) or magnetic resonance imaging (MRI) (2–5). This evidence concerns the gene AFP and hepatocellular carcinoma.